Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography

Archives of Dermatology

Volumn 132, Issue 8, 1996, Pages 875-880

  Böni, Roland ^a   Huch Böni, Rahel A ^a   Steinert, Hans ^a   Von Schulthess, Gustav K ^a   Burg, Günter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; FLUORODEOXYGLUCOSE F 18; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPISTAXIS; HUMAN; MALE; MELANOMA; METASTASIS POTENTIAL; NOSE CANCER; PHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; TUMOR BIOPSY;

DEOXYGLUCOSE; ETHMOID SINUS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MAXILLARY NEOPLASMS; MELANOMA; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029793211     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.8.875     Document Type: Article

References (5)

1. Böni R, Much Böni RA, Steinert H, et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol. 1995;132:556-562.
2. Steinert HC, Much Böni RA, Buck A, et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology. 1995;195:705-709.
3. Hoh CK, Hawkins RA, Glaspy JA, et al. Cancer detection with whole-body PET using 2-(18F) fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr. 1993;17:582-589.
4. Warburg O. The Metabolism of Tumors. New York, NY: Richard R Smith Inc; 1931:129-169.
5. Blessing C, Feine V, Geiger L, Carl M, Rassner G, Fierlbeck G. Positron emission tomography and ultrasonography. Arch Dermatol. 1995;131:1394-1398.